Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery
1 other identifier
interventional
154
1 country
1
Brief Summary
The aim of this trial is to compare preoperative Imunnonutrition with standard enteral nutrition regarding morbidity after major abdominal surgery in patients with NRS greater 3. The primary end point is the complication rate until 30 days after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2007
CompletedFirst Posted
Study publicly available on registry
August 7, 2007
CompletedStudy Start
First participant enrolled
September 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedApril 24, 2012
April 1, 2012
3.3 years
August 6, 2007
April 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
complications after surgery
30 days
Secondary Outcomes (1)
hospital stay, patient compliance, Interleukin-6 and 10 plasma level
30 days
Study Arms (2)
1
ACTIVE COMPARATORImmunonutrition containing RNA, omega-3-FAs, arginine
2
ACTIVE COMPARATORStandard enteral nutrition: isocaloric and isonitrogeneous but w/o active ingredients
Interventions
Impact vs Meritene
Impact vs Meritene
Eligibility Criteria
You may qualify if:
- All patients admitted for elective major abdominal surgery:
- Open and laparoscopic esophageal, gastric, hepatic, pancreatic, intestinal and colorectal surgery and with a NRS ≥ 3.
You may not qualify if:
- Age \< 18 years
- No informed consent
- Emergency situation
- Patients not speaking french or german.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Lausanne Hospitalslead
- Novartiscollaborator
Study Sites (1)
Department of Visceral Surgery, University Hospital Center
Lausanne, 1011, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nicolas Demartines, MD
Department of Visceral Surgery, University Hospital Center, Lausanne, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor of surgery
Study Record Dates
First Submitted
August 6, 2007
First Posted
August 7, 2007
Study Start
September 1, 2007
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
April 24, 2012
Record last verified: 2012-04